XBIO - Xenetic Biosciences Inc
Previous close
3.865
0 0%
Share volume: 421
Last Updated: Thu 29 Aug 2024 06:00:00 AM CEST
Research and Development in Biotechnology (except Nanobiotechnology):
0.21%
PREVIOUS CLOSE
CHG
CHG%
$3.86
0.00
0.00%
Summary score
13%
Profitability
0%
Dept financing
5%
Liquidity
49%
Performance
20%
Sector
Professional, Scientific, and Technical Services
Industry
Research and Development in Biotechnology (except Nanobiotechnology)
Long-term ratios 30-Jun-2016 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last 4 years.
Return on equity
-20.79%
Return on assets
-8.58%
Return on sales
-859.65%
Return on invested capital
-26.15%
Total debt ratio
29.32%
Debt ratio change over timeo
-2.09%
Current Ratio
3.06%
Quick Ratio
0%
Cash Position Ratio
2.76%
Short-term ratios 30-Jun-2019 - 30-Jun-2020
The data are presented for the financials results of the quarters of the last year.
Return on equity
-31.32%
Return on assets
-8.33%
Return on sales
0%
Return on invested capital
-67.61%
Total debt ratio
19.81%
Debt ratio change over timeo
-1.91%
Current Ratio
9.6%
Quick Ratio
0%
Cash Position Ratio
8.67%
Last quarter ratios 30-Jun-2020
The data are presented for the financials results of the last quarter.
Return on equity
-6.21%
Return on assets
-5.15%
Return on sales
0%
Return on invested capital
-10.41%
Total debt ratio
19.44%
Debt ratio change over time
-1.16%
Current Ratio
11.58%
Quick Ratio
0%
Cash Position Ratio
10.25%
Performance ratios (change over 4 years) 30-Jun-2016 - 30-Jun-2020
The data are presented for the change financials results of the quarter of the last 4 years.
Return on equity
-3.09%
Return on assets
-67.95%
Return on sales
3003.81%
Return on invested capital
41.6%
Total debt ratio
-209.07%
Debt ratio change over time
-2.09%
Current Ratio
-13.04%
Quick Ratio
0%
Cash Position Ratio
-10.41%
Compare in sector
The following table compares the individual analyzes for the other top 3 stocks within the same industry.
| Long-term ratios | XBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -20.79% | -3.05% | 11.55% | 6.27% |
| Return on assets | -8.58% | 3.6% | 3.57% | 5.27% |
| Return on sales | -859.65% | 32.14% | 42.16% | 33.08% |
| Return on invested capital | -26.15% | 5.09% | 7.99% | 13.19% |
| Profitability | 0% | 46% | 82% | 83% |
| Total debt ratio | 29.32% | 101.18% | 74.11% | 29.58% |
| Debt ratio change over time | -2.09% | 6.09% | 6.03% | 1.53% |
| Dept financing | 7% | 50% | 43% | 14% |
| Current Ratio | 9.6% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 46% | 27% | 55% | 59% |
| Short-term ratios | XBIO | ABBV | AMGN | REGN |
|---|---|---|---|---|
| Return on equity | -31.32% | -25.62% | 17.94% | 7.14% |
| Return on assets | -8.33% | 3.26% | 3.67% | 4.71% |
| Return on sales | 0% | 31.22% | 37.5% | 33.58% |
| Return on invested capital | -67.61% | 8.14% | 7.17% | 18.16% |
| Profitability | 0% | 49% | 79% | 82% |
| Total debt ratio | 19.81% | 105.33% | 83.42% | 27.49% |
| Debt ratio change over time | -1.91% | -23.44% | 9.66% | 0.6% |
| Dept financing | 5% | 25% | 45% | 8% |
| Current Ratio | 9.6% | 2.08% | 2.02% | 3.51% |
| Quick Ratio | 0% | 1.96% | 1.71% | 2.86% |
| Cash Position Ratio | 8.67% | 1.48% | 0.76% | 1.49% |
| Liquididy | 50% | 27% | 22% | 38% |